Yi Yu
10Patents
2h-index
27Co-inventors
50Inventor score
Filing activity: Dec 1, 2006 → Jul 26, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8603457B2 | Nonsense suppression and genetic codon alteration by targeted modification | Human Necessities | 10 | Active |
| US9273294B2 | Targeted 2′-O-methylation of telomerase non-coding RNA | Chemistry; Metallurgy | 3 | Active |
| US11155803B2 | Adenosine deaminase base editors and methods of using same to modify a nucleobase in a target sequence | Chemistry; Metallurgy | 2 | Active |
| US11752202B2 | Compositions and methods for treating hemoglobinopathies | Chemistry; Metallurgy | 1 | Active |
| US11344609B2 | Compositions and methods for treating hemoglobinopathies | Chemistry; Metallurgy | 1 | Active |
| US11142760B2 | Compositions and methods for treating hemoglobinopathies | Chemistry; Metallurgy | 1 | Active |
| US9949981B2 | Compositions and methods for treating proliferation disorders | Emerging Cross-Sectional Technologies | 0 | Active |
| US11866702B2 | Nucleic acid molecules for pseudouridylation | Chemistry; Metallurgy | 0 | Active |
| US12016908B2 | Compositions and methods for treating hemoglobinopathies | Chemistry; Metallurgy | 0 | Active |
| US9238813B2 | Targeted pre-mRNA/mRNA modification and gene regulation | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.